Bacterial lipopolysaccharides (LPS) induce innate immune inflammatory responses in endothelial cells by activating toll-like receptor 4 (TLR4) signalling. Here, we investigate the effects of angiopoietin-1 (Ang-1) on LPS-induced TLR4 signalling and the role of the miR-146 family of micro RNAs in the effects of Ang-1 on TRL4 signalling.
Introduction
Sepsis, the most common cause of death in non-coronary intensive care units, is associated with strong activation of inflammatory and coagulation pathways. Activation occurs as a result of interactions between pathogens and pattern recognition receptors localized on the surface of several cell types, including monocytes, macrophages, and endothelial cells (ECs). Injection of lipopolysaccharide (LPS), a fat-polysaccharide complex in the outer cell membrane of gram-negative bacteria, triggers many of the clinical manifestations of sepsis, including fever, hypotension, shock, and multiple organ failure. 1 Pathogen-or LPS-induced activation of ECs occurs in two phases-a rapid phase that is largely independent of the protein transcription process (type I) and a slow phase that requires new protein synthesis or gene up-regulation (type II). Angiopoietin-1 (Ang-1) and endothelial-specific receptor tyrosine kinase (Tie-2) are important modulators of angiogenesis and inflammation. Both are essential to embryonic vascular development 3, 4 and, in the mature vasculature, Ang-1 is necessary for vascular integrity and survival of ECs. 5 Ang-1 also stimulates EC migration and angiogenesis at sites of active vascular remodelling. 6, 7 Accumulating evidence indicates that Ang-1 regulates both phases of EC activation in sepsis although the nature of regulation varies depending, in part, on the length of exposure to Ang-1. For instance, exposure to Ang-1 for a few minutes increases translocation of the adhesion molecule P-SELECTIN to cell membranes and enhances leucocyte adhesion to ECs, a response that lasts for 15 min. 8 This rapid, transient, pro-inflammatory effect has been attributed to Ca 2+ release and the activation of phospholipase C gamma (PLCg) and is similar to the response of ECs stimulated with vascular endothelial growth factor (VEGF). 9 Ang-1 also elicits transient antiinflammatory effects such as rapid attenuation of vascular leakage, a response that has been linked to sequestration of Src kinases by mammalian diaphanous (mDIA) and to inhibition of nitric oxide (NO) production. 10 -12 While transient exposure triggers both pro-and anti-inflammatory effects, longer exposures to Ang-1 elicit strong anti-inflammatory effects. For example, when ECs are exposed for 1 -6 h to Ang-1 combined with VEGF or TNFa, the presence of Ang-1 significantly decreases VEGF-or TNFa-induced leucocyte adhesion to ECs, trans-endothelial migration of leucocytes, and the expressions of vascular cell adhesion molecule-1 (VCAM1), intracellular adhesion molecule-1 (ICAM1), and E-SELECTIN. 13 -15 These anti-inflammatory effects have been attributed to transient up-regulation of nerve growth factor IB (Nur77), the transcription factor KLF2, and the binding of the interacting protein ABIN2 to Tie-2 receptors. 14 -16 Prolonged exposure to Ang-1, that is, exposure in the order of 12 h or more, is also associated with strong anti-inflammatory effects. For instance, elevating systemic Ang-1 levels for several days results in significant decreases in LPS-induced leucocyte infiltration into the lungs, vascular leakage, and mortality in mice. 8, 17, 18 The mechanisms by which Ang-1 inhibits LPS-induced inflammatory responses remain unclear. One possible mechanism is that Ang-1 inhibits signalling of tolllike receptor 4 (TLR4), which is a transmembrane receptor that detects LPS, leading to the activation of host defense mechanisms by mediating signal transductions that stimulate critical immune responses such as the release of pro-inflammatory cytokines. 19 Activation of TLR4 initiates an intracellular signalling cascade that involves mitogen-activated protein kinases (MAPKs) such as p38, SAP/JNK, and ERK1/2, myeloid differentiation primary response gene 88 (MYD88), interleukin 1 receptorassociated kinases 1 (IRAK1) and 4 (IRAK4), TNF receptor-associated factor 6 (TRAF6), and several transcription factors, including nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB), activating protein 1 (AP-1), and interferon regulatory factor 3 (IRF3). 19 It is as yet unclear as to exactly where in this signalling cascade Ang-1 may exert its action.
Since so little information is available on Ang-1 regulation of TLR4 signalling, the first objective of this study is to determine the effects of prolonged Ang-1 exposure on LPS-induced inflammatory responses in ECs. We hypothesize that prolonged Ang-1 exposure significantly inhibits LPS-induced inflammatory responses and that this inhibition occurs through disruption of TLR4 signalling.
One possible mechanism by which Ang-1 may disrupt the TLR4 cascade is by up-regulating selective microRNAs (miRNAs) that directly target proteins involved in TLR4 signalling. The miR-146 family of miRNAs comprises two genes, miR-146a and miR-146b, whose mature forms share the same 'seed' sequence, suggesting that they might target the same transcripts. As a way of controlling excessive inflammation, several families of miRNAs, including the miR-146 family, 20 target TLRs and associated downstream signalling proteins.
Both miR-146a and miR-146b directly target the signal transducers IRAK1 and TRAF6, which amplify the signalling cascades initiated by TLRs. No information is as yet available regarding Ang-1 regulation of the miR-146 family of miRNAs or the role miRNAs may play in the regulation of Ang-1 as an anti-inflammatory agent. The second objective of this study, therefore, is to determine the functional roles of the miR-146 family of miRNAs in relation to Ang-1 inhibition of LPS-induced inflammatory responses in ECs. We hypothesize that prolonged Ang-1 exposure leads to up-regulation of selective members of the miR-146 family and that this up-regulation plays a significant role in regulating Ang-1 inhibition of inflammation.
Methods

Cell culture
Human umbilical vein endothelial cells (HUVECs) were isolated from umbilical cords as previously described. 21 All procedures were approved by the ) were washed, re-suspended in 300 mL of MCDB 131 medium, and then co-incubated with HUVEC monolayers for 1 h at 378C using a rocking platform. Cells were washed three times with PBS then fixed in 4% paraformaldehyde. Adhered U937 cells were counted in 10 fields per well using inverted fluorescence microscopy (Olympus IX70, Olympus America, Melville, NY, USA).
mRNA analysis
Total RNA was extracted using a GenElute TM Mammalian Total RNA Miniprep Kit (Sigma-Aldrich, St Louis, MO) according to the manufacturer's protocol. Specific mRNAs were detected using real-time PCR with specific primers (see Supplementary material online, Materials), SYBR w green, and a 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA). Pri-miR-146b was detected using TaqMan w assays (Applied Biosystems). 18S and b-ACTIN were used as control genes. All experiments were performed in triplicate. Relative mRNA expression was determined using the comparative threshold (C T ) method (2 2DDCT ) as previously described. 22 
MiRNA analysis
Total RNA was extracted using TRIzol w (Invitrogen) and an miRNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturers' protocols. MiRNAs were detected using an NCode TM miRNA qRT-PCR Kit (Invitrogen) and real-time PCR with specific primers (Supplementary material online, Materials), SYBR w green, and a 7500 Real-Time PCR System. All experiments were performed in triplicate. Relative miRNA expression was determined using the C T method, where C T values of individual miRNA data were normalized to C T values of U6 snRNA.
Immunoblotting
Total cell lysates (Supplementary material online, Materials) were separated using SDS -PAGE, transferred onto polyvinylidene difluoride (PVDF) membranes, blocked with 5% milk, then probed overnight at 48C with specific primary antibodies. Proteins were detected using HRP-conjugated secondary antibodies and ECL reagents as previously described. 23 
Analysis of NF-kB promoter activity
HUVECs were incubated for 6 h in serum-free media containing 100 multiplicity of infection (MOI) units of adenovirus expressing NFkB luciferase reporter (Ad5 HSV-NFkB-luc) (Gene Transfer Vector Core, U of Iowa, Iowa City, IA, USA) then allowed to recover for 48 h prior to experimental treatment. 24 Firefly luciferase activity was quantified using a Dual-Luciferase w Reporter Assay System (Promega, Madison, WI, USA) normalized for cell protein levels and is expressed in relative light units.
Transfection with miRNA mimics and inhibitors
HUVECs were transfected with 50 nM of a synthetic mature miRNA mimic (Shanghai Genepharma, Shanghai, China) or 50 nM of miScript miRNA Inhibitor (Qiagen) using Lipofectamine TM RNAiMAX (Invitrogen) according to the manufacturers' instructions. All experimental treatments were performed 48 h after transfection.
ELISA
Interleukin 6 (IL6) and interleukin 8 (IL8) concentrations in cell-culture supernatants were measured using an OptEIA TM cytokine kit (BD Biosciences, Franklin Lakes, NJ, USA) and a DuoSet w ELISA Development System (R&D Systems, Minneapolis, MN, USA), respectively, according to the manufacturers' instructions.
3
′ UTR Luciferase constructs pMIR-REPORT TM plasmids containing 500 bp of wild-type 3 ′ UTRs of IRAK1 (IRAK1-wt UTR) and TRAF6 (TRAF6-wt UTR) cloned downstream of a CMV-driven Firefly Luciferase cassette were generated by Taganov et al. 25 Mutated versions of these constructs (IRAK1-mut-UTR, TRAF6-mut-UTR) carrying 4-bp substitutions in the miR-146 target sites were constructed by site-directed mutagenesis. 25 HUVECs were co-transfected with one of these plasmids and a Renilla luciferase vector (pRL-TK). Cells were allowed to recover for 24 h, starved for 6 h in MCDB 131 medium, and then maintained for 24 h in medium containing PBS or Ang-1. Firefly and Renilla luciferase activities were quantified using a Dual-Luciferase w Reporter Assay System and Firefly luciferase activity was normalized for Renilla activity to control for transfection efficiency differences.
Data analysis
Data are expressed as means + standard error (SEM). Statistical significance determined by two-way analysis of variance with Newman -Keuls post-hoc test. A P-value of 0.05 or less was considered statistically significant.
Results
LPS-induced inflammatory responses
HUVECs were pre-incubated for 24 h with PBS or Ang-1 (300 ng/mL) then exposed to Escherichia coli LPS (10 mg/mL) for 4 or 6 h. Leucocyte adhesion, EC viability, adhesion molecule expression, and cytokine production were measured. With PBS pre-incubation, LPS exposure for 4 h does not affect EC viability (Supplementary material online, Materials) but triggers significant increases in leucocyte adhesion, adhesion molecule expression, and pro-inflammatory cytokine production ( Figure 1 ). LPS does not affect the expressions of the anti-inflammatory cytokines IL4 and IL10 ( Figure 1 ). With Ang-1 pre-incubation, LPS triggers significantly smaller increases than those observed with PBS ( Figure 1 ). When HUVECs are simultaneously exposed to LPS and Ang-1 for 4 h, LPS-induced up-regulation of adhesion molecule expression and cytokine production is not affected (Supplementary material online, Materials). These results indicate that the inhibitory effects of Ang-1 on LPS-induced responses in HUVECs require prolonged exposure to Ang-1 (24 h).
LPS-induced TLR4 signalling
HUVECs were pre-incubated for 24 h with PBS or Ang-1 (300 ng/mL) then exposed to vehicle (0 time) or E. coli LPS (10 mg/mL) for 10, 60, and 120 min. MAPK and p65 subunit of NFkB phosphorylation, NFkB luciferase reporter activity, and IkBa protein levels were measured. With PBS, LPS triggers significant increases in the phosphorylation of p38, SAPK/ JNK, ERK1/2, and the p65 subunit of NFkB, significant increases in NFkB activity, and significant decreases in IkBa protein levels ( Figure 2 ). With Ang-1, LPS triggers significantly less p38, SAPK/JNK, and p65 phosphorylation, significantly less NFkB activity, and significantly greater IkBa than that observed with PBS. Ang-1 has no effect on ERK1/2 phosphorylation ( Figure 2 ). Ang-1 has no effects on TRL4, MYD88, IRAK4, or TAK1 mRNA expression and protein levels ( Figure 3A and B and Supplementary material online, Materials), but significantly decreases IRAK1 and TRAF6 protein levels by 80% ( Figure 3A and B).
Ang-1 regulation of miRNA expression
HUVECs were pre-incubated for 12, 24, or 48 h with PBS or Ang-1 (300 ng/mL), then expressions of miR-146a and miR-146b were measured with real time PCR. Ang-1 exerts no effects on the expressions of miR-146a-3p and miR-146a-5p (Supplementary material online, Materials). When compared with results observed with PBS, Ang-1 exerts no effect on the expression of miR-146b-3p but significantly increases miR-146b-5p expression, particularly after 12 h ( Figure 3C ). Ang-1 activates the p38, SAPK/JNK, and ERK1/2 members of mitogenactivated protein kinases (MAPKs) in ECs. 22, 26 To investigate the involvement of these signalling pathways in the regulation of miR146b-5p expression, HUVECs were pre-incubated for 2 h with PD184352 (MEK1/2 inhibitor, 2 mM), SB203580 (p38 inhibitor, 15 mM), or SP600125 (SAPK/JNK inhibitor, 10 mM). Cells were then incubated with PBS or Ang-1 for 24 h. Results indicate that SB203580 exerts no effect on Ang-1-induced miR-146b-5p expression ( Figure 3D ). PD184352 and SP600125 both inhibit Ang-1-induced miR-146b-5p expression, indicating the involvement of the ERK1/2 and SAPK/JNK pathways ( Figure 3D ). To assess whether Ang-1-induced increases in miR-146b-5p are due to increased transcription, precursor ( pri-miR-146b) levels were measured following pre-incubation with Ang-1 for 2, 6, 10, and 12 h ( pri-miR-146b is processed from a single exon transcript on chromosome 10). Pri-miR-146b transcript levels significantly increase after 6 and 10 h then decline to basal levels after 12 h ( Figure 3E ). In comparison, miR-146b-5p levels significantly and progressively increase after 10 and 12 h ( Figure 3E ).
To determine the effects of other angiogenesis factors in the regulation of miR-146b-5p expression, HUVECs were pre-incubated for 24 h with PBS, vascular endothelial growth factor (VEGF, 40 ng/mL), fibroblast growth factor 2 (FGF-2, 10 ng/mL), or angiopoietin-2 (Ang-2, 300 ng/mL). VEGF and FGF-2 exert no effects on miR-146b-5p expression but it is significantly reduced by Ang-2 ( Figure 3F ).
miR-146b-5p regulation of LPS-induced responses
HUVECs were transfected with a control mimic or a miR-146b-5p mimic. After 48 h of recovery, cells were exposed to vehicle (control) or LPS for 4 or 6 h. Leucocyte adhesion, adhesion molecule expression, and cytokine production were measured. Experiments were performed to verify that transfection with miR-146b-5p mimic results in significant increases in miR-146b-5p expression (Supplementary material online, Materials). With the control mimic, LPS triggers significant increases in leucocyte adhesion, adhesion molecule expression (VCAM1, ICAM1, E-SELECTIN), and cytokine production (TNFa, IL1b, IL6, IL8) ( Figure 4) . With the miR-146b-5p mimic, LPS triggers significantly less leucocyte adhesion, adhesion molecule expression, and cytokine production than that observed with the control mimic ( Figure 4) .
To determine the effects of miR-146b-5p on TLR4 signalling, HUVECs were transfected with a control mimic or a miR146-5p mimic then exposed to vehicle (0 time) or LPS for 10, 60, and 120 min. p-38, SAPK/ JNK, ERK1/2 phosphorylation, and NFkB reporter activity was measured. With the control mimic, LPS triggers significant increases in p38, SAPK/JNK, ERK1/2 phosphorylation, and NFkB activity ( Figure 5 ). With the miR-146b-5p mimic, LPS triggers significantly less p38 and SAPK/ JNK phosphorylation ( Figure 5A ), significantly less NFkB activity Figure 5B), and no change in ERK1/2 phosphorylation when compared with that observed with the control mimic ( Figure 5A) . To determine the effects of miR-146b-5p on IRAK1 and TRAF6, HUVECs were transfected with a control mimic or a miR-146b-5p mimic and mRNA and protein levels were measured 48 h later. Neither the control nor the 146b-5p mimic elicits any significant differences in IRAK1 and TRAF6 mRNA levels ( Figure 5C ). With the miR-146b-5p mimic, there are significantly lower protein levels of IRAK1 and TRAF6 than those observed with the control mimic ( Figure 5D and E).
miR-146b-5p regulation of Ang-1 inhibition of TLR4
To determine whether miR-146b-5p mediates Ang-1 inhibition of LPSinduced TLR4 signalling, HUVECs were transfected with a miScript w control miRNA inhibitor or a miScript w miR-146b-5p inhibitor, allowed to recover for 36 h, pre-incubated for 24 h with PBS or Ang-1, then exposed to vehicle (control) or LPS for 4 or 6 h. Leucocyte adhesion and cytokine production were measured. Transfection with Angiopoietins and microRNAs miR-146b-5p inhibitor results in significant decreases of miR-146b-5p expression (Supplementary material online, Materials). With the control miRNA inhibitor and PBS, LPS triggers significant increases in leucocyte adhesion and cytokine production ( Figure 6 ). With the control inhibitor and Ang-1, LPS triggers significantly less leucocyte adhesion and cytokine production than that observed with PBS ( Figure 6 ). With the miR-146b-5p inhibitor and either PBS or Ang-1, there are no significant differences in leucocyte adhesion or cytokine production ( Figure 6 ).
To confirm that miR-146b-5p regulates Ang-1 inhibition of LPSinduced TLR4 signalling through selective targeting of IRAK1 and TRAF6, HUVECs were transfected with wild-type (IRAK1-wt and TRAF6-wt) or mutated IRAK1 and TRAF6 (IRAK1-mut and TRAF6-mut) 3 ′ UTR luciferase reporters ( Figure 7A ) then pre-incubated for 24 h with PBS or Ang-1. Relative luciferase activity and protein levels were measured. With wild-type plasmids, Ang-1 triggers significantly lower IRAK1 and TRAF6 3 ′ UTR luciferase activities than those observed with PBS ( Figure 7B and C ) . Mutation of the miR-146b-5p targeting sequence ( Figure 7A ) reverses this effect ( Figure 7B and C). To confirm that the effects of miR-146b-5p on expression of IRAK1 and TRAF6 are mediated through selective binding to specific targeting sites located at the 3 ′ UTR, HUVECs were co-transfected with a control mimic or a miR-146b-5p mimic and IRAK1-wt or TRAF6-wt reporter plasmids.
Relative luciferase activity was measured 48 h later. With the miR146b-5p mimic, IRAK1-wt and TRAF6-wt reporter activities are significantly lower than those observed with the control mimic ( Figure 7D) .
To determine the effects of a miR-146b-5p inhibitor on Ang-1-induced changes in IRAK1 and TRAF6 protein levels, HUVECs were transfected with a control inhibitor or miR-146b-5p inhibitor and exposed to PBS or Ang-1. With the control inhibitor, IRAK1 and TRAF6 protein levels are significantly lower in response to Ang-1 than those observed with PBS ( Figure 7E and F ) . With the miR-146b-5p inhibitor, IRAK1 and TRAF6 protein levels remain unchanged relative to those observed with PBS ( Figure 7E and F ) .
Discussion
The main findings of this study are:
(i) Prolonged exposure to Ang-1 inhibits LPS-induced leucocyte adhesion, adhesion molecule expression, pro-inflammatory cytokine production, p38 and SAPK/JNK phosphorylation, and NFkB activation; (ii) Prolonged exposure to Ang-1 selectively inhibits the expressions of two proteins that are critical to TLR4 signalling, IRAK1 and TRAF6; (iii) Prolonged exposure to Ang-1 triggers significant up-regulation of miR-146b-5p expression as a result of enhanced transcription of pri-miR-146b; (iv) miR-146b-5p inhibits LPS-induced leucocyte adhesion, adhesion molecule expression, pro-inflammatory cytokine production, p38 and SAPK/JNK phosphorylation, and NFkB activation, and selectively attenuates IRAK1 and TRAF6 expressions by targeting their 3 ′ UTR sequences and consequently impairing translation;
(v) Inhibition of miR-146b-5p reverses Ang-1 inhibition of LPS-induced leucocyte adhesion, cytokine production, NFkB activation, and IRAK1 and TRAF6 protein expressions.
ECs play an important role in initiating and sustaining host innate immune responses, 27 in part through the anti-inflammatory effects of the Ang-1/ Tie-2 receptor axis. In murine sepsis models, for example, Ang-1 exposure or selective Tie-2 receptor activation improves haemodynamic function, increases survival, and attenuates inflammatory cell infiltration into the lungs. 17, 18, 28 The mechanisms through which the Ang-1/Tie-2 axis exerts these effects, however, are still under investigation. Recent attention has focused on how adhesion molecules and cytokines interact with TLR4, a protein that plays an important role in the innate immune system, but it is yet unknown as to how Ang-1 regulates TLR4 signalling in ECs in response to inflammation. It has been reported that significant attenuation of TNFa-and VEGF-induced leucocyte adhesion occurs after 4-6 h of Ang-1 exposure, a result of decreased activation of the adhesion molecules VCAM1, ICAM1, and E-SELECTIN. 14, 15, 29 These studies show a clear role for
Ang-1 in the regulation of adhesion molecules in response to inflammation. It is also clear that TRL4 signal transduction is involved in LPSinduced activation of adhesion molecules and pro-inflammatory cytokines. 30 TLR4 activation triggers a cascade of signalling events that involves MYD88, IRAK1, IRAK4, TRAF6, and MAPKs (p38, SAPK/JNK, ERK1/2), culminating in early-and late-phase activation of the transcription factors NFkB and AP-1. 30 To date, however, there has been very little information as to how Ang-1 interacts with TLR4 in ECs. We report here for the first time that prolonged exposure to Ang-1 triggers strong inhibition of LPS-induced leucocyte adhesion and adhesion molecule expression in ECs and link its role as anti-inflammatory agent to selective disruption of TLR4 signalling. We also report here for the first time that prolonged exposure to Ang-1 triggers strong inhibition of LPS-induced production of TNFa, IL1b, IL6, and IL8 and suggest that this anti-inflammatory response is mediated by p38, SAPK/JNK, and NFkB pathway inhibition (Figure 2 ). Activation and nuclear translocation of NFkB downstream from TLR4 requires phosphorylation of IkB kinase (IKK) complex by TGFb-activated kinase 1 (TAK1) and subsequent degradation of IkBa. 31 We found that prolonged exposure to Ang-1 not only decreases LPS-induced degradation of IkBa, but also decreases p65 subunit of NFkB phosphorylation and NFkB luciferase reporter activity ( Figure 2) . We suggest that disruption of TLR4 signalling is the primary mechanism responsible for this, although secondary mechanisms may also be involved. One such mechanism is direct binding of Tie-2 receptors to the A20-binding protein ABIN2, 32 which directly inhibits NFkB activation. This explanation is bolstered by a study that shows that an exogenous form of ABIN2 that has lost its ability to inhibit NFkB disrupts Ang-1 rescue of ECs from growth factor deprivation-induced apoptosis. 16 Another possible mechanism involves nerve growth factor IB (Nur77), a nuclear receptor that has been reported to negatively regulate TNFa-and IL1b-induced NFkB activation in ECs by transcriptionally up-regulating IkBa expression. 33 A mechanistic role for Nur77 is supported by our recent study that shows that Ang-1 transiently up-regulates Nur77 in ECs and strongly inhibits VEGF-induced leucocyte adhesion and NFkB activation.
14 MAPK and NFkB activation downstream of TLR4 depends upon MYD88 to recruit IRAK1, IRAK4, TRAF6, and the TAK1 complex. 19 We report here that prolonged exposure to Ang-1 decreases IRAK1 and TRAF6 protein levels but has no effect on TLR4, MYD88, IRAK4, or TAK1 mRNA or protein levels ( Figure 3 ). IRAK1 and TRAF6 are fundamental components of the signal transduction cascades activated by TLRs. 19 For several reasons, we think that prolonged Ang-1 exposure disrupts LPS-induced TLR4 signalling by down-regulating IRAK1 and TRAF6 protein expressions. First, in IRAK1-deficient mice, p38, SAPK/ JNK, and NFkB activation and TNFa and IL6 production are attenuated downstream of TLR4 and IL1 receptor (IL1R). 34 Secondly, IRAK1-deficient mice are less susceptible to the lethal effects of LPS as compared with their wild-type counterparts. 35 Thirdly, in response to TLR signalling, adhesion molecules and pro-inflammatory cytokines display defective expression in TRAF6-deficient mice. 36 These studies, in combination with our data, suggest that prolonged exposure to Ang-1, resulting in decreased IRAK1 and TRAF6 protein levels, affects the magnitude of the inflammatory response to LPS downstream of TLR4. MiR-146a and miR-146b are transcribed from two different chromosomes and their expressions may vary depending on the cell type and the nature of the stimulus. In immune cells, both miR-146a and miR-146b are induced by pro-inflammatory stimuli such as LPS, TNFa, IL1b, and viral infection. 25, 37, 38 In alveolar epithelial cells, NFkB transcription factor induces miR-146a but does not induce miR-146b. 39 Little is as yet known about the regulation or functional significance of either miR-146a or miR-146b in ECs although Fish et al. 40 have reported that both are enriched in ECs isolated from differentiating embryonic stem cells and, more recently, Chen et al. 41 have reported recently that both are strongly induced in ECs in response to pro-inflammatory cytokines such as IL1b and TNFa. Interactions between angiogenesis factors and miR-146a and miR-146b in ECs have scarcely been studied at all and we report for the first time that prolonged exposure of HUVECs to Ang-1 triggers significant induction of miR-146b-5p but not of miR-146a. Two other pro-angiogenic factors, VEGF and FGF-2, exert no effects on miR-146b-5p, suggesting that miR-146b-5p is selectively up-regulated by Ang-1.
The steady-state level of mature miRNA is influenced by three factors: transcription, processing, and decay. In this study, we found that Ang-1 significantly induces pre-miR-146b, which indicates that Ang-1-induced augmentation of miR-146b-5p is mediated, in part, through increased transcription. Furthermore, we found that Ang-1 induction of pre-miR146b is transient and develops at earlier time points (6 and 10 h) than for miR-146b-5p ( Figure 3E ). This kinetic profile-of early induction of the primary transcripts followed by delayed up-regulation of the mature forms of miR-146a and miR-146b-has also been described in IL1b-and LPS-stimulated ECs and fibroblasts and has been attributed to the relatively long stability of mature miRNAs. 41, 42 Indeed, Gantier et al., 42 by selectively knocking down the Dicer1 gene, concluded that mature miRNAs, including miR-146a, have relatively long half-lives compared with precursor transcripts. It should be emphasized, however, that our study does not rule out the possibility that Ang-1 may also affect miR-146b-5p levels through selective regulation at the processing level.
To investigate the cellular pathways through which Ang-1 regulates miR-146b, we used selective pharmacological inhibitors of the p38, SAPK/JNK, and ERK1/2 pathways because it is well known that these pathways are Ang-1-activated and that they mediate a number of biological effects of Ang-1 such as migration, differentiation, and survival. 23, 26, 43, 44 We found that Ang-1-induced up-regulation of miR146b-5p requires the SAPK/JNK and ERK1/2 pathways but not the p38 pathway ( Figure 3 ). In congruence with our results, previous studies have reported that IL1b-induced miR-146b expression in ECs and in A549 human lung carcinoma cells also requires both pathways.
39,41
The transcription factors through which the SAPK/JNK and ERK1/2 pathways regulate miR-146b expression remain to be determined. In IL1b-stimulated ECs, ERK1/2 induction of miR-146b is mediated through EGR-3. 41 To the best of our knowledge, it is EGR-1, rather than EGR-3, that is activated downstream from the ERK1/2 pathway in Ang-1-stimulated ECs. 44 The extent to which EGR-1 regulates miR146b in ECs remains to be investigated. One interesting observation in our study is that prolonged exposure to Ang-2 dramatically decreases miR-146b-5p expression, suggesting that Ang-1 and Ang-2 exert opposing regulatory effects on miR-146b. Ang-2 potentiates responses to pro-inflammatory stimuli. Ang-2 deficient mice are unable to elicit the normal rapid and pro-inflammatory response to TNF-a and are incapable of inducing adhesion molecule expression. 45 Ang-2 inhibition of miR-146a and miR-146b-5p suggests that its pro-inflammatory role may be mediated by their attenuation, although the functional importance of the miR-146 family to Ang-2 regulation would need to be explored more fully before any conclusions could be made. Despite structural similarities between miR-146a and miR-146b, their biological functions are distinct and non-redundant. It has been well established that miR-146a is involved in inflammation, endotoxin tolerance, myeloid cell proliferation, and cancer. 46 In contrast, miR-146b-5p
has been associated with a number of non-inflammation-related cellular processes. For instance, it regulates the TGF-b signalling pathway by targeting SMAD4 and modulates cell migration by targeting epidermal growth factor receptor (EGFR) and matrix metalloproteinase 16 (MMP16). 47, 48 We thought that it may also be a regulator of TLR signalling and, as such, its precise functions in relation to innate immunity and inflammation required further inquiry. Therefore, we used a mimic of mature miR-146b-5p to demonstrate that it inhibits LPS-induced leucocyte adhesion, adhesion molecule expression, and cytokine production in ECs. We also found that it strongly attenuates LPS-induced p38 and SAPK/JNK activation and NFkB luciferase reporter activity. According to Taganov et al., 25 the mature form of miR-146a alone functions as a negative feedback regulator of NFkB activity. Our findings, however, demonstrate that miR-146b-5p attenuates LPS-induced NFkB activation in ECs, suggesting that one of its functions is also to limit LPS-induced activation of TLR4 signalling in the vasculature through selective binding of specific sites. This hypothesis is supported by the fact that miR-146b-5p decreases protein levels and relative luciferase activities of IRAK1 and TRAF6 (Figure 4) . This confirms previous studies that have identified IRAK1 and TRAF6 as direct targets of miR-146b-mediated regulation 25 and links them to the regulation of LPS-induced signalling in ECs. More importantly, we suggest here that Ang-1 inhibits IRAK1 and TRAF6 by up-regulating miR-146b-5p, which binds to specific targeting sites located at the 3 ′ UTR of these proteins. This suggestion is supported by two primary observations. First, we found that Ang-1 strongly inhibits wild-type 3 ′ UTR reporter activities of IRAK1 and TRAF6 and that this inhibition disappears when miR-146b-5p targeting sites have been mutated (Figure 4) . Secondly, we transfected cells with a selective inhibitor of miR-146b-5p and re-assessed the effects of prolonged Ang-1 exposure on LPS-induced responses. We found that the miR-146b-5p inhibitor reversed the inhibitory effects of Ang-1 on LPS-induced leucocyte adhesion, cytokine production, and IRAK1 and TRAF6 protein expressions ( Figure 6 ). This study would be greatly enhanced by the inclusion of in vivo data on the role of miR-146b-5p in Ang-1-mediated inhibition of LPS-induced inflammatory responses in the vasculature. It should be emphasized that it was only after prolonged exposure of cultured ECs to Ang-1 that up-regulation of miR-146b-5p and disruption of TLR4 signalling were observed (Figures 1-3 ). Due to rapid degradation of recombinant Ang-1 protein, it is extremely challenging at the technical level to induce the kind of prolonged elevation of Ang-1 that would model physiological levels in the intact vasculature. Additional technical issues arise when using Ang-1-expressing adenoviruses because they elevate serum Ang-1 levels to those far exceeding physiological levels. Furthermore, because in vivo effects of Ang-1 on LPS-induced responses are likely to be so complex that they would involve modulation of TLR4 signalling in more types of cells than just ECs, such as leucocytes and vascular smooth muscle cells, a separate, comprehensive in vivo study is warranted to address these issues.
In summary, we report here that prolonged exposure to Ang-1 inhibits LPS-induced leucocyte adhesion, adhesion molecule expression, cytokine production, pro-inflammatory mediator expression, and activation of the p38, SAPK/JNK, and NFkB pathways. We also demonstrate that Ang-1 inhibition of LPS-induced inflammatory responses is mediated through disruption of the TLR4 signalling pathway at the protein expression level of IRAK1 and TRAF6, two signal transducers that are direct targets of miR-146b-5p. These results provide evidence for a novel mechanism of Ang-1 inhibition of inflammation in response to bacterial infection and establish a baseline for further studies on the roles of angiopoietins in TLR4-mediated vascular immune responses.
